ARTICLE | Company News
Antigen Express Inc. other research news
March 27, 2000 8:00 AM UTC
Antigen Express received a $173,000 Phase I SBIR grant from the National Cancer Institute to develop a colon cancer vaccine using cancer cells transfected with the MHC Class II transactivator gene (CI...